A therapeutic target has been identified that brings us closer to the goal of preventing brain metastases and avoiding relapses
A team of Spanish researchers has investigated the early stages of metastatic cells taking hold in target organs and has discovered that there is a transitional stage during which these ‘metastatic seeds’ are particularly vulnerable. They have also demonstrated in mice and in human samples that these micrometastases can be eliminated using three drugs, two of which are already approved for other indications. The study is published in the journal Cancer Cell.
0
